3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3225SP |
Nuedexta®, Serum/Plasma |
3250SP |
Oxalate, Serum/Plasma |
3265B |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Blood |
3265SP |
Oxcarbazepine / Eslicarbazepine Acetate as Metabolite, Serum/Plasma |
3310B |
Paraldehyde and Metabolite, Blood |
3310SP |
Paraldehyde and Metabolite, Serum/Plasma |
3310U |
Paraldehyde and Metabolite, Urine |
3320SP |
Paramethadione, Serum/Plasma |
3433SP |
Perampanel, Serum/Plasma |
3707B |
Phenylethylmalonamide, Blood |
3707SP |
Phenylethylmalonamide, Serum/Plasma |
3743B |
Phenytoin, Blood |
3743FL |
Phenytoin, Fluid |
3743SP |
Phenytoin, Serum/Plasma |
3743TI |
Phenytoin, Tissue |
3901SP |
Primidone, Serum/Plasma |